Prof Sir Chris Evans
Group Chairman
Sir Chris is regarded as one of Europe's leading biotechnology entrepreneurs. He has a proven track record of establishing successful, high-quality science companies, 20 of which have been taken public. These compa...
Martin Walton
Managing Director
Martin is CEO responsible for all the investment and business activities of Excalibur and its subsidiary companies. In addition to managing Excalibur's existing activities, this involves the evaluation, implementation an...
Jeremy Curnock Cook
Director
Jeremy has over 20 years experience in the medical sciences field. Since August 2000, he founded and has served as executive chairman of BioScience Managers Limited, a corporate and investment advisory firm. From 1987 to...
Dr Max Link
Chairman, Merlin General Partner II and III
NCPharma Scientific Advisory Board
Max is a highly experienced executive director and non-executive director in the industry. A former CEO of Sandoz Pharma, he served as chairman of the CytRX Corporation, Alexion Pharmaceuticals Inc., t...
Professor Trevor Jones
Board Member Merlin General Partner II
NCPharma Scientific Advisory Board
Trevor is a main board director of The Wellcome Foundation where he has been responsible for R&D, including the development of AZT, Zovirax, Lamictal, Malarone and other medicines. A director of Allergan I...
Dr Hellmut Kirchner
Board Member, Merlin General Partner II and III
Hellmutt co-founded VCM Venture Capital Management Gmbh, now Sal Oppenheim Private Equity Partners GmbH. In 1983 founded TVM Techno Venture Management GmbH, a venture capital management company sponsored by Siem...
